Safety and Immunogenicity Among Adults of Fluzone, Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route)
Phase of Trial: Phase IV
Latest Information Update: 24 May 2013
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza A virus infections
- Focus Adverse reactions
- Sponsors Sanofi
- 01 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Aug 2012 Planned end date changed from 1 Feb 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 04 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.